However, the company reported a 72 percent revenue increase to $9.1 million in the fourth quarter and a 96 percent increase to $30.1 million in 2011. Over the past year, the company acquired assets of Robinson MedSurg and entered into a $31 million equity purchase agreement with Lincoln Park Capital Fund.
During the fourth quarter, the company completed a two-year study of its OsteoSponge, showing equivalence to rhBMP-2 in spinal fusion.
More Articles on Orthopedic Devices:
10 Milestones for Spine Devices
Global Orthopedic Prosthetics to Reach $23.5B by 2017
15 of the Most Profitable Orthopedic & Spine Device Companies in 2011
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.